ABAT and adrenal cortex carcinoma: Of particular note, transcripts encoding GABA’s metabolizing enzyme, ABAT, are upregulated in more than 40% of ACC tumors, and its high expression is associated with favorable clinical attributes, including a three-fold increase in patient survival time.